Viriom
Developing novel and affordable therapies against life threatening infections such as HIV and HBV
Viriom has raised €1.9M across 1 funding round from 2 investors, most recently a Early VC round in May 2016. Based in Khimki, Russia; founded 2009; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€1.9M
€1,950,000
Funding rounds
1
Investors
2
distinct backers
Active since
2016-05
latest 2016-05
Funding by year
EUR raised per yearViriom — funding by year — interactive chart.
Data table
| Viriom — funding by year | |
|---|---|
| 2016 | €1.9M |
Signals
High confidenceRaise-next likelihood8
base rate 42% for Early VC
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-05-01 | Early VC | €1.9M | ChemRar Ventures,Torrey Pines Investment | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData